From Protocol to Patient: Inside Clinical Supply
The global biopharmaceutical industry, a beacon of scientific innovation, faces an intricate journey in translating...
Knowledge and News for the Global Fight Against Cancer.
The global biopharmaceutical industry, a beacon of scientific innovation, faces an intricate journey in translating...
The biopharmaceutical sector is witnessing a transformative period marked by aggressive technological adoption, strategic mergers...
Tempus AI has announced its definitive agreement to acquire Personalis, a leading innovator in molecular...
Westlake, CA – July 20, 2026 – Latigo Biotherapeutics, a pioneering biotechnology firm headquartered in...
The biotechnology sector’s resurgence on public markets gained further traction this week with Attovia Therapeutics...
New data emerging from a clinical trial conducted in China have provided what Wall Street...
The pharmaceutical industry stands at a pivotal juncture, with artificial intelligence (AI) heralded as a...
London-based pharmaceutical giant GSK has announced the discontinuation of its camlipixant development program, a P2X3...
The biopharmaceutical industry finds itself navigating a complex legal and scientific terrain this week, marked...
In a pivotal move to reverse its flagging fortunes, Jasper Therapeutics, a biotechnology company that...